Small molecule inhibitors – Unlocking the potential of iPSC-based therapeutics

2 Dec 2024

Explore the potential of induced pluripotent stem cells (iPSCs) for disease modeling, drug discovery, and regenerative medicine, alongside the challenges of scalability and manufacturing. Discover how FUJIFILM’s newly launched complete CEPT cocktail and GMP-grade y-27632 rock inhibitor support both upstream and downstream processes, offering comprehensive solutions for all stages of iPSC-based therapy development.

Links

Tags